Diabetes and Bone: Still a Lot to Learn

作者: Joumana T. Chaiban , Kristine G. Nicolas

DOI: 10.1007/S12018-015-9178-9

关键词:

摘要: Both type 2 diabetes mellitus (T2DM) and osteoporosis are increasing worldwide. There is a large body of knowledge pointing to the association these two diseases with potential increased risk falls fractures in patients diabetes. Whereas 1 have low bone mineral density (BMD), those T2DM tend high BMD rendering task difficult for clinicians diagnose “weakness” identify at higher fractures. The duration glycemic control seem affect fracture risk. Several underlying pathophysiologic pathways factors increasingly linking glucose homeostasis. Factors secreted by such as osteocalcin osteoprotegerin metabolism, while hyperglycemia, insulin advanced glycation end products appear disrupt quality. Adipocytokines, mainly leptin adiponectin, major players pathophysiology diseases. Vitamin D parathyroid hormone, main regulators calcium an important role too. Yet, there still some controversy surrounding few mechanisms interactions. In this review, we will summarize available evidence illustrating intimate interaction between homeostasis highlight studies examining fall

参考文章(131)
Aydan C Celebiler, Baysal Karaca, Aylin Dogan, Sibel Bilgili, Inverse relationship between adiponectin and plasminogen activator inhibitor-1 in metabolic syndrome patients. Endocrine Regulations. ,vol. 42, pp. 63- ,(2008)
Uriel M. Malyankar, Marta Scatena, Katherine L. Suchland, Theodore J. Yun, Edward A. Clark, Cecilia M. Giachelli, Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells Journal of Biological Chemistry. ,vol. 275, pp. 20959- 20962 ,(2000) , 10.1074/JBC.C000290200
Eleanor J Hothersall, Shona J Livingstone, Helen C Looker, S Faisal Ahmed, Steve Cleland, Graham P Leese, Robert S Lindsay, John McKnight, Donald Pearson, Sam Philip, Sarah H Wild, Helen M Colhoun, None, Contemporary Risk of Hip Fracture in Type 1 and Type 2 Diabetes: A National Registry Study From Scotland Journal of Bone and Mineral Research. ,vol. 29, pp. 1054- 1060 ,(2014) , 10.1002/JBMR.2118
Paulus LA van Daele, Ronald P Stolk, Huibert Burger, Douwe Algra, Diederik E Grobbee, Albert Hofman, Jan C Birkenhager, Huibert AP Pols, Bone Density in Non-Insulin-Dependent Diabetes Mellitus: The Rotterdam Study Annals of Internal Medicine. ,vol. 122, pp. 409- 414 ,(1995) , 10.7326/0003-4819-122-6-199503150-00002
Dominic J. Withers, Julio Sanchez Gutierrez, Heather Towery, Deborah J. Burks, Jian-Ming Ren, Stephen Previs, Yitao Zhang, Dolores Bernal, Sebastian Pons, Gerald I. Shulman, Susan Bonner-Weir, Morris F. White, Disruption of IRS-2 causes type 2 diabetes in mice Nature. ,vol. 391, pp. 900- 904 ,(1998) , 10.1038/36116
Patricia Ducy, Michael Amling, Shu Takeda, Matthias Priemel, Arndt F Schilling, Frank T Beil, Jianhe Shen, Charles Vinson, Johannes M Rueger, Gerard Karsenty, Leptin Inhibits Bone Formation through a Hypothalamic Relay: A Central Control of Bone Mass Cell. ,vol. 100, pp. 197- 207 ,(2000) , 10.1016/S0092-8674(00)81558-5
R. Dhaliwal, D. Cibula, C. Ghosh, R. S. Weinstock, A. M. Moses, Bone quality assessment in type 2 diabetes mellitus. Osteoporosis International. ,vol. 25, pp. 1969- 1973 ,(2014) , 10.1007/S00198-014-2704-7
Mathieu Ferron, Jianwen Wei, Tatsuya Yoshizawa, Andrea Del Fattore, Ronald A. DePinho, Anna Teti, Patricia Ducy, Gerard Karsenty, Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy Metabolism Cell. ,vol. 142, pp. 296- 308 ,(2010) , 10.1016/J.CELL.2010.06.003
C. De Laet, J. A. Kanis, A. Odén, H. Johanson, O. Johnell, P. Delmas, J. A. Eisman, H. Kroger, S. Fujiwara, P. Garnero, E. V. McCloskey, D. Mellstrom, L. J. Melton, P. J. Meunier, H. A. P. Pols, J. Reeve, A. Silman, A. Tenenhouse, Body mass index as a predictor of fracture risk: A meta-analysis Osteoporosis International. ,vol. 16, pp. 1330- 1338 ,(2005) , 10.1007/S00198-005-1863-Y